13F Holdings
中文EN

AVAH Aveanna Healthcare Holdings, Inc.

Services-Home Health Care Services · Nasdaq · SEC CIK 1832332 · Fiscal year ends 01/01

Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.8%
TTM net income YoY305.7%
TTM EPS YoY278.4%
Revenue 3-yr CAGR12.7%
Net income 3-yr CAGR—

Margins

Gross margin32.3%
Operating margin11.4%
Net margin11.4%
FCF margin—
EBITDA margin11.8%

Returns

ROE176.7%
ROA15.2%
ROIC (approx.)23.4%
Asset turnover1.33x

Leverage & solvency

Liabilities / assets84.7%
Debt / equity3.84x
Current ratio1.23x
Interest coverage2.61x

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio4.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-01-03FY20242024-12-28FY20232023-12-30FY20222022-12-31FY20222022-01-01
Income statement
Revenue$2.43B$2.02B$1.90B$1.79B$1.68B
Cost of revenue$1.62B$1.39B$1.30B$1.23B$1.14B
Gross profit$810.48M$635.54M$595.43M$553.23M$542.40M
SG&A expense$374.50M$352.81M$360.98M$357.23M$297.38M
Operating income$256.46M$139.79M$8.07M-$642.28M-$36.11M
Interest expense$140.09M$156.60M$153.25M$107.72M$68.93M
Pretax income$106.95M$5.07M-$139.00M-$663.81M-$113.58M
Income tax-$118.09M$16.00M-$4.47M-$1.78M$3.47M
Net income$225.03M-$10.93M-$134.52M-$662.03M-$117.04M
EBITDA$267.00M$150.56M$21.85M-$620.96M-$15.56M
EPS (basic)1.11-0.06-0.71-3.57-0.69
EPS (diluted)1.05-0.06-0.71-3.57-0.69
Weighted avg. shares (diluted)214.98M192.89M189.96M185.55M170,625
Balance sheet
Cash & equivalents$193.26M$84.29M$43.94M$19.22M$30.49M
Receivables$313.36M$265.19M$236.56M$221.24M$218.92M
Current assets$560.23M$392.67M$314.89M$269.75M$279.21M
PP&E, net$16.65M$17.37M$20.55M$22.75M$31.37M
Goodwill$1.12B$1.05B$1.05B$1.16B$1.84B
Intangibles$92.56M$89.57M$94.01M$95.86M$102.85M
Total assets$2.01B$1.66B$1.61B$1.71B$2.33B
Current liabilities$424.46M$402.17M$354.76M$326.50M$344.83M
Short-term debt$13.25M$9.20M$9.20M$9.20M$8.60M
Long-term debt$1.29B$1.27B$1.28B$1.28B$1.23B
Total debt$1.30B$1.28B$1.29B$1.29B$1.24B
Total liabilities$1.82B$1.79B$1.74B$1.72B$1.70B
Shareholders' equity$194.46M-$123.55M-$129.57M-$6.31M$635.82M
Net debt$1.11B$1.20B$1.24B$1.27B$1.20B
Shares outstanding211.00M193.23M190.73M188.86M184.73M
Cash flow statement
Operating cash flow$125.86M$32.64M$22.67M-$48.40M-$11.35M
Capital expenditure————$15.95M
Free cash flow————-$27.30M
Investing cash flow-$22.30M-$6.32M-$8.79M-$25.29M-$681.83M
Financing cash flow$5.41M$14.03M$10.85M$62.42M$586.33M
Depreciation & amortization$10.54M$10.78M$13.78M$21.31M$20.55M
Stock-based compensation$25.06M$17.46M$13.16M$15.89M$14.43M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.